Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Orego-Stim is a 100% natural phytogenic feed additive containing high-quality oregano essential oil, which is rich in active phenolic compounds such as carvacrol and thymol. Developed by Anpario (and historically by Meriden Animal Health), it is widely used in livestock, poultry, and aquaculture to support gut health, improve feed conversion efficiency, and promote growth. The active components, carvacrol and thymol, exert potent antimicrobial, antioxidant, and anti-inflammatory effects. They primarily act by disrupting the cell membranes of gastrointestinal pathogens (such as *Escherichia coli*, *Salmonella* spp., *Clostridium perfringens*, and *Eimeria* spp.), leading to cell lysis and death. This helps prevent and manage intestinal infections like coccidiosis and necrotic enteritis, serving as a natural alternative to antibiotic growth promoters.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Orego-Stim.